Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?
A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...
Auteurs principaux: | Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Frontiers Media
2021
|
Documents similaires
-
Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
par: Helen L. Stark, et autres
Publié: (2021-03-01) -
An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
par: Alzhrani, AI
Publié: (2021) -
Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
par: Honeyman, C, et autres
Publié: (2021) -
Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
par: Honeyman, C, et autres
Publié: (2020) -
Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
par: Maja-Theresa Dieterlen, et autres
Publié: (2021-08-01)